SERYNTH HEMORRHOID
NDC 85248-155, Lidocaine 4% Phenylephrine HCL 0.25% HEMORRHOID, cream, from Jiangxi Yudexi Pharmaceutical Co., LTD.
- Product NDC
- 85248-155
- Status
- Listed
- Labeler
- Jiangxi Yudexi Pharmaceutical Co., LTD
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M017
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85248-155 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIDOCAINE4 g/100g
- PHENYLEPHRINE HYDROCHLORIDE.25 g/100g
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85248-155-01 | 85248015501 | 20 g in 1 TUBE (85248-155-01) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 85248-155 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85248-155 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85248-155. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.